Esomeprazole structure 
             | 
        Common Name | Esomeprazole | ||
|---|---|---|---|---|
| CAS Number | 161973-10-0 | Molecular Weight | 713.121 | |
| Density | N/A | Boiling Point | 600ºC at 760 mmHg | |
| Molecular Formula | C34H36MgN6O6S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 316.7ºC | |
            Use of EsomeprazoleEsomeprazole magnesium is an inhibitor of H+, K+-ATPase, effectively used in the research of upper intestinal disorder.  | 
    
| Name | esomeprazole magnesium | 
|---|---|
| Synonym | More Synonyms | 
| Description | Esomeprazole magnesium is an inhibitor of H+, K+-ATPase, effectively used in the research of upper intestinal disorder. | 
|---|---|
| Related Catalog | |
| Target | 
                                    
                                     H+, K+-ATPase[1]  | 
                            
| In Vitro | Esomeprazole magnesium is an inhibitor of H+, K+-ATPase[1]. | 
| In Vivo | Esomeprazole magnesium (0.5, 5, 50 mg/kg/day, p.o.) produces increased gastric total antioxidant capacity, decreases gastric lipid peroxide levels, significantly increases superoxide dismutase levels, but shows no obvious effect on colonic lipid peroxide levels in mice[1]. | 
| Animal Admin | Mice[1] In this 10-day supplementation experiment, mice (n = 10/group) receive the following: 1) as a control group, only the vehicle for dissolution of Esomeprazole (PEG-400) given orally once daily by gastric gavage; 2) Esomeprazole 0.5 mg/kg in an equivalent volume of PEG-400 given orally once daily by gastric lavage; 3) Esomeprazole 5 mg/kg in an equivalent volume of PEG-400 given orally once daily by gastric lavage; and 4) Esomeprazole 50 mg/kg in an equivalent volume of PEG-400 given orally once daily by gastric lavage[1]. | 
| References | 
| Boiling Point | 600ºC at 760 mmHg | 
|---|---|
| Molecular Formula | C34H36MgN6O6S2 | 
| Molecular Weight | 713.121 | 
| Flash Point | 316.7ºC | 
| Exact Mass | 712.198792 | 
| PSA | 186.82000 | 
| LogP | 6.78900 | 
| Vapour Pressure | 2.35E-14mmHg at 25°C | 
| Storage condition | -20℃ | 
| (-)-Omeprazole magnesium | 
| Nexium | 
| H-199/18 | 
| omeprazole magnesium | 
| EsMeprazole Magne-siuM Trihydrate | 
| sulfonium, hydroxy(6-methoxy-1H-benzimidazol-2-yl)[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-, inner salt, magnesium salt (2:1) | 
| H 199/18 | 
| (T-4-(S),(S))-Bis(5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazolato)magnesium | 
| (S)-Omeprazole magnesium | 
| (T-4)-Bis(5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl-kO)-1H-benzimidazolato-kN1)magnesium | 
| Magnesium bis(5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl}benzimidazol-1-ide) | 
| Esomeprazole magnesium | 
| 1H-Benzimidazole, 5-methoxy-2-[(S)-[(1S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, magnesium salt (2:1) | 
| Magnesium bis{(6-methoxybenzimidazol-1-id-2-yl)[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfoniumolate} | 
| Magnesium bis(5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide) | 
| Esomeprazole |